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The promoter sequences from -175 to + 10 of the mouse whey acidic protein (WAP) gene are a target for sequence- 
specific binding of nuclear proteins [(1987) Nucleic Acids Res. 15,2103-21211. Using in vitro transcription assays based 
on nuclear extracts, transcription factors were shown to bind to these sequences and promoter upstream sequences were 
found to stimulate transcription. 
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1. INTRODUCTION 
Whole cell [l] or nuclear [2] extracts can mediate 
transcriptional initiation by RNA polymerase II 
from gene promoters which are not expressed in the 
respective cell type in vivo [3-61. This most likely 
reflects a greater permissiveness of in vitro systems 
which have lost components present in vivo and 
contain general factors which are neither cell- nor 
tissue-specific, but sufficient to initiate and sustain 
transcription from cloned DNA templates. Thus, 
soluble transcription systems from non-homolo- 
gous cell types can be used to test the functionality 
of DNA templates with different sequences, and to 
search for gene-specific regions whose effects are 
manifested by interactions with protein factors in- 
volved in transcription. 
We used these properties of in vitro transcription 
systems for an analysis of transcriptional elements 
in the mouse whey acidic protein (WAP) promoter 
[7]. The mouse WAP gene has been shown to be ex- 
pressed preferentially in the mammary gland of 
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lactating animals under the influence of steroid and 
peptide hormones. Low-level expression can also 
be observed in non-mammary tissue of wild-type 
and transgenic mice [B] suggesting that the WAP 
promoter is also subject to the action of general 
transcription factors. Since transfection assays into 
tissue culture cells did not yield information about 
transcriptional elements within the WAP pro- 
moter, soluble in vitro transcription systems ap- 
peared to be an alternative. Here, we demonstrate 
that in vitro transcription from the WAP promoter 
is initiated accurately in several cell types and that 
sequences upstream of the promoter, which bind 
specific nuclear proteins [9], augment transcrip- 
tion. 
2. MATERIALS AND METHODS 
2.1. Plasmids 
The mouse WAP gene template [7] was isolated as a 640 bp 
Hinfl fragment (-410 to 230), treated with mung bean nuclease 
and cloned into the SmaI site of plasmid pTZl8R (Pharmacia). 
In the resulting plasmid, named WAP-HH640, the Hind111 site 
of the polylinker was located downstream of the promoter. The 
plasmid HCMV-Pro contains the promoter (-55 to 7) of the 
human cytomegalovirus (HCMV) immediate arly 1 (IEl) gene 
[lo] cloned into the EamHI site of pUCl3. HCMV-WAPI con- 
tains the DraI fragment (-175 to -25) of the mouse WAP gene 
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linked to the HCMV IEl promoter of HCMV-Pro. HCMV- 
WAPII contains the DraI fragment in reverse orientation. 
2.2. DNA fragments 
The following DNA fragments were prepared from the WAP 
gene 5’ flanking region: DraI-DraI (-175 to -25), DraI-XbaI 
(-175 to -88), XbaI-KpnI (-88 to 24). The DNA fragments were 
prepared from a low-melting agarose gel. 
2.3. Preparation of nuclear extracts 
Nuclear extracts were prepared from mammary epithelial 
(T47D), Burkitt Lymphoma (Raji), HeLa and B-cells according 
to Dignam et al. [2] and the protein concentrations were assayed 
according to Bradford [l I]. 
2.4. In vitro transcription assays 
The incubation mixture for the transcription reaction (25~1) 
contained 12 mM Hepes at pH 7.9, 10% glycerol, 1.6 mM 
dithiothreitol, 0.12 mM EDTA, 60 mM KCI, 2 mM MgClz, 5 U 
placental ribonuclease inhibitor (Amersham), 300 FM ATP, 
CTP and GTP, 30 PM UTP, [‘*P]UTP (100 000 cpm/pmol), 70 
pg nuclear protein, and 0.5 pg template DNA. After 45 min in- 
cubation at 3O”C, the reaction was stopped and processed as 
described 121. The RNA was subjected to electrophoresis in a 
4% sequencing el. In the competition assay, 35 pg nuclear pro- 
tein and 0.125 pg DNA template were used. Nuclear proteins 
were incubated for 15 min with competitor DNA. Upon adding 
template and nucleotides, incubation was continued for 45 min. 
In each assay using specific fragments, the amount of com- 
petitor DNA was adjusted to 200 ng using poly(dI-dC). 
2.5. Transfection and transient expression 
Transfection of plasmids HCMV-Pro, HCMV-WAPI and 
HCMV-WAPII into T47D and HeLa cells was performed using 
the standard calcium phosphate precipitation technique. CAT 
activities were measured with [‘4C]chloramphenicol by standard 
procedures. 
3. RESULTS AND DISCUSSION 
Our initial attempts to derive transcription ex- 
tracts from homologous tissues involved mouse 
mammary glands. We found that nuclear extracts 
prepared from this tissue were not capable of cor- 
rectly initiating transcription from the WAP gene 
and other cellular and viral gene templates. This 
prompted us to examine nuclear extracts from a 
mammary cell line and other human cell lines for 
their transcriptional activity. Run-off transcription 
assays were performed with nuclear proteins from 
different cell types which contain transcription fac- 
tors capable of promoting accurate transcriptional 
initiation from gene templates [ 121. The plasmid 
WAP-HH640 containing the mouse WAP pro- 
moter was truncated at the Hind111 site in the 
polylinker, which is located about 260 nucleotides 
3’ of the start site of transcription, and at the 
174 
EcoRI site in the polylinker, which is located about 
440 nucleotides 5 ’ of the start site. We focused on 
this region of the WAP gene because sequences fur- 
ther upstream of the promoter did not affect in 
vitro transcription (not shown). In the in vitro 
transcription assay run-off transcripts with a size 
of 263 nucleotides were generated by nuclear pro- 
teins from T47D, Raji, HeLa and B-cells (fig. 1A). 
This indicates that the WAP promoter can be ac- 
tivated in vitro by proteins from cell types derived 
from different lineages. This is in contrast o the in- 
tact animal where the WAP promoter is preferen- 
tially active in the lactating mammary gland [8]. 
Using nuclear extract from the human mammary 
cell line T47D we investigated several transcrip- 
tional properties of the WAP promoter. Transcrip- 
tion from the WAP promoter is sensitive to 0.5 
pg/ml cll-amanitin, indicating that it is dependent 
on polymerase II (fig. 1B). Efficiency of in vitro 
transcription can be dependent on the concentra- 
tion of Mg2+ [1,2]. The WAP promoter is 
transcribed best in the presence of 6 mM MgCL, 
but is also active over a wide concentration range 
of Mg2+ (fig. 1C). The ability of the in vitro system 
to initiate transcription at the start site used in vivo 
was confirmed by using templates truncated at the 
BarnHI or XbaI sites which result in run-off 
transcripts of 233 and 239 bp, respectively (fig. ID, 
lanes 3,4). 
Having established apolymerase II-dependent in 
vitro transcription system for the WAP gene, we 
analyzed its promoter sequences for their ability to 
modulate transcription. Using restriction enzymes 
we deleted specific sequences from the promoter 
and analyzed the resulting templates using nuclear 
extracts from T47D cells. Deleting sequences 
upstream of the SstI site at - 354 did not alter the 
level of run-off transcripts (fig. lD, lane 2). Addi- 
tional deletion of sequences between - 88 and 
- 354 resulted in a significant reduction of in vitro 
transcripts (fig. ID, lane 4). Restricting the 
template with XbaI at - 88 leads to the loss of 
DNA sequences which are recognized by nuclear 
protein from several cell types including mammary 
epithelial cells [9], and concomitantly leading to 
the destruction of additional sites of protein-DNA 
interaction located over the XbaI site. This sug- 
gested that the sites of protein-DNA interaction in 
the WAP promoter are involved in transcriptional 
stimulation in vitro. 
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Fig.1. In vitro transcription from WAP gene promoter 
templates. In (A-C) we used as template the plasmid WAP- 
HH600 cut with Hind111 and EcoRI. (A) Run-off transcription 
assay with nuclear extract from Raji (lane l), B-cells (lane 2) 
T47D cells (lane 3) and HeLa cells (lane 4). The arrow indicates 
the transcript of 263 nucleotides. (B) Transcription in nuclear 
extract from T47D cells in the absence (lane 1) or presence of 0.5 
pg/ml (lane 2) or 200 pg/ml a-amanitin (lane 3). (C) Effect of 
Mg* + on transcription from the WAP promoter in T47D ex- 
tract. Lanes: (1) 2 mM, (2) 4 mM, (3) 6 mM, (4) 8 mM, (9) 10 
mM Mg’+. (D) Transcription from WAP deletion mutants in 
T47D extract. The following templates were used (lanes): (1) 
WAP-HH600 cut with EcoRI and ZfindIII, (2) cut with S&I and 
ZflndIII, (3) cut with EcoRI and BamHI, (4) cut with XkI. The 
numbers indicate the size of the respective transcripts in 
nucleotides. The map at the top shows the WAP promoters and 
important restriction sites are indicated. HF, HinfI; Ss, SstI; 
Dr, DraI; Xb, XbaI; Kp, KpnI. 
An alternative way of studying the role of DNA- 
binding proteins in the transcriptional activation of 
promoters involves competition assays with 
specific DNA fragments [13,14]. As shown in fig. 
2, incubation of the extract with fragments from 
the WAP gene promoter prior to adding the 
template resulted in decreased transcription. The 
DraI-DraI (- 175 to - 25) fragment which con- 
tains several protein binding sites [9] competed well 
at low excess (fig. 2, lane 3-5). Effective reduction 
of transcription by the DraI-XbaI (- 175 to - 88) 
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Fig.2. Effect of specific competitor fragments on the in vitro 
transcriptional activity of the WAP promoter. The plasmid 
WAP-HH600 was cut with EcoRI and Hind111 and used as 
template in T47D cell nuclear extract in the absence of com- 
petitor DNA (lane l), 200 ng poly(dI-dC) (lane 2), 50, 100 and 
150 ng Drd-Drd fragment (lanes 3-5), 50, 100 and 150 ng 
XbaI-KpnI fragment (lanes 6-8) and 50, 100 and 150 ng Drd- 
XbaI fragment (lanes-9-l 1). 
and XbaI-KpnI (- 88 to 24) fragments was observ- 
ed at higher concentration of competitor DNA (fig. 
2, lanes 6-11). The presence of nonspecific com- 
petitor DNA [poly(dI-dC)] led to an increase of 
transcription. These data show that specific 
transcription factors interact with the WAP pro- 
moter upstream region. A significant feature of the 
DruI-XbaI fragment is a conserved sequence motif 
[consensus sequence: TGGCAAGSCTGGGCST- 
(G)YTCTCTCT(NTG)TGGCAARA] which can 
be found in similar positions in the promoters of 
four whey protein genes and which is recognized by 
nuclear proteins in the mouse WAP [9] and rat (Y- 
lactalbumin gene [15]. This suggests that this con- 
served sequence is involved in transcriptional 
regulation of the WAP and other milk protein 
B 
Fig.3. Transient expression of the HCMV 1El gene promoter in 
the presence or absence of the WAP upstream region. Lanes l-3 
show CAT expression in T47D (A) and HeLa cells (B). CAT ac- 
tivity directed by plasmids HCMV-WAPI (lanes l), HCMV- 
WAPII (lanes 2) and HCMV-PRO (lanes 3). 
175 
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genes. The protein binding sites in the WAP and (Y- 
lactalbumin genes contain similar sequences 
(TGGCARNNWCKKC) [ 151 which resemble part 
of the nuclear factor 1 binding site and which is 
recognized by purified nuclear factor 1 from HeLa 
cells (not shown). Therefore, nuclear factor l-like 
proteins can be involved in the transcriptional 
regulation of some milk protein genes. Recently, it 
has been shown that nuclear factor 1 binding sites 
can stimulate transcription in vivo [16,17] and in 
vitro [18]. 
Since the WAP promoter upstream region ac- 
tivates the homologous promoter, we addressed the 
question as to whether this region can also enhance 
transcription from a heterologous promoter. The 
DraI-DruI fragment in which the WAP TTTAAA 
box is absent, was linked to the promoter of the 
human cytomegalovirus (HCMV) immediate early 
1 @El) gene. We chose the IEl promoter because it 
can be activated by the IEl enhancer, which like 
the WAP upstream region contains nuclear factor 
l-like binding sites [19]. In in vivo transfection 
assays in T47D and HeLa cells we observed a 
3-5-fold stimulatory effect by the WAP upstream 
region on the HCMV promoter in both orienta- 
tions (fig. 3). 
Our results suggest hat upstream sequences of 
the mouse WAP promoter, which are recognized 
by nuclear proteins [9], have the capability of in- 
creasing transcription in vitro. This region also 
enhances transcription from the HCMV promoter 
in vivo, indicating that the WAP gene sequence 
between - 175 and - 25 can act as a functional 
promoter upstream element. Since we could not 
measure activity of the upstream region in the con- 
text of the WAP TTTAAA box and surrounding 
sequences in transient expression assays, it is possi- 
ble that this TTTAAA box is a target for transcrip- 
tional repression. 
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